Form 4 for ACAD ACADIA PHARMACEUTICALS INC
Accepted 2021-11-23 00:00:00 ET · period of report 2021-11-19 · accession 0001209191-21-066570 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-11-23 | 2021-11-19 | ACAD | Stankovic Srdjan R. | Pres | M - OptEx | — | +6,250 | 44.3K | +16% | — |
| D | 2021-11-23 | 2021-11-22 | ACAD | Stankovic Srdjan R. | Pres | S - Sale+OE | $19.01 | -2,803 | 41.5K | -6% | -$53.3K |
| D | 2021-11-23 | 2021-11-19 | ACAD | Stankovic Srdjan R. | Pres | M - OptEx | $0.00 | -6,250 | 6,250 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-11-19 | M | A | 6,250 | — | 44,315 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. |
| 2 | Common | Common Stock | 2021-11-22 | S | D | 2,803 | $19.01 | 41,512 | D | — | — | |
| 3 | Derivative | Restricted Stock Units | 2021-11-19 | M | D | 6,250 | $0.00 | 6,250 | D | — · — to — | 6,250 Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock. (F3) The restricted stock units vest in four equal annual installments beginning 11/19/2019. |